Clinical Evidence
Linking Hypothermia and Hyperglycemia
Setting: 571-bed acute care hospital (named among Top 100 cardiovascular hospitals in U.S.).
Objective
This case study examines the impact of using a computer-guided glucose management software system (EndoTool) for post-cardiac arrest patients undergoing induced hypothermia, a therapy with known risks of decreased insulin secretion and insulin sensitivity.
Setting
571-bed acute care hospital (named among Top 100 cardiovascular hospitals in U.S.).
Results
- With traditional paper protocols, intravenous insulin titration required complex manual calculations and overall glucose control was inadequate, often including hyperglycemia followed by hypoglycemia.
- With EndoTool, calculations for intravenous insulin titration were made by the system, nurses noted that glucose levels were quickly controlled, and there were no hypoglycemia events.
Conclusions
Use of a computer-guided glucose management software system (EndoTool) for intravenous insulin titration delivers demonstrably better outcomes than traditional paper protocols for patients undergoing induced hypothermia.
References
Authors
Tracey Melhuish, RN, MSN.
Source
Published in Nursing Management, Volume 40, Issue 12, p42-45.
Year
2009
Related posts
Clinical Evidence
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment
The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Clinical Evidence
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
20 minute read
Achieving Optimal Glucose Control in Critical Care Units at Atrium Health
The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Clinical Evidence
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings
To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch
Ready to get started?
Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.
"*" indicates required fields